361 related articles for article (PubMed ID: 18841205)
1. The global programme to eliminate lymphatic filariasis: health impact after 8 years.
Ottesen EA; Hooper PJ; Bradley M; Biswas G
PLoS Negl Trop Dis; 2008 Oct; 2(10):e317. PubMed ID: 18841205
[TBL] [Abstract][Full Text] [Related]
2. The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).
Chu BK; Hooper PJ; Bradley MH; McFarland DA; Ottesen EA
PLoS Negl Trop Dis; 2010 Jun; 4(6):e708. PubMed ID: 20532228
[TBL] [Abstract][Full Text] [Related]
3. A refined and updated health impact assessment of the Global Programme to Eliminate Lymphatic Filariasis (2000-2020).
Turner HC; Ottesen EA; Bradley MH
Parasit Vectors; 2022 May; 15(1):181. PubMed ID: 35643508
[TBL] [Abstract][Full Text] [Related]
4. The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).
Hooper PJ; Bradley MH; Biswas G; Ottesen EA
Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S17-21. PubMed ID: 19843394
[TBL] [Abstract][Full Text] [Related]
5. The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000-2014).
Turner HC; Bettis AA; Chu BK; McFarland DA; Hooper PJ; Ottesen EA; Bradley MH
Infect Dis Poverty; 2016 May; 5(1):54. PubMed ID: 27388873
[TBL] [Abstract][Full Text] [Related]
6. Progress toward elimination of lymphatic filariasis--Togo, 2000--2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(29):989-91. PubMed ID: 21796097
[TBL] [Abstract][Full Text] [Related]
7. Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease.
Ramaiah KD; Ottesen EA
PLoS Negl Trop Dis; 2014 Nov; 8(11):e3319. PubMed ID: 25412180
[TBL] [Abstract][Full Text] [Related]
8. Setting the stage for a Global Programme to Eliminate Lymphatic Filariasis: the first 125 years (1875-2000).
Ottesen EA; Horton J
Int Health; 2020 Dec; 13(Suppl 1):S3-S9. PubMed ID: 33349877
[TBL] [Abstract][Full Text] [Related]
9. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
[TBL] [Abstract][Full Text] [Related]
10. Elimination of lymphatic filariasis as a public health problem in Malawi.
Chiphwanya J; Mkwanda S; Kabuluzi S; Mzilahowa T; Ngwira B; Matipula DE; Chaponda L; Ndhlova P; Katchika P; Mahebere Chirambo C; Moses P; Kumala J; Chiumia M; Barrett C; Betts H; Fahy J; Rebollo Polo M; Reimer L; Stanton MC; Thomas B; Freer S; Molyneux DH; Bockarie MJ; Mackenzie CD; Taylor MJ; Martindale S; Kelly-Hope LA
PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011957. PubMed ID: 38363794
[TBL] [Abstract][Full Text] [Related]
11. How Thailand eliminated lymphatic filariasis as a public health problem.
Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
[TBL] [Abstract][Full Text] [Related]
12. Soil transmitted helminths and scabies in Zanzibar, Tanzania following mass drug administration for lymphatic filariasis--a rapid assessment methodology to assess impact.
Mohammed KA; Deb RM; Stanton MC; Molyneux DH
Parasit Vectors; 2012 Dec; 5():299. PubMed ID: 23259465
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Lymphatic Filariasis Mass Drug Administration Scaling Down on Soil-Transmitted Helminth Control in School-Age Children. Present Situation and Expected Impact from 2016 to 2020.
Mupfasoni D; Montresor A; Mikhailov A; King J
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005202. PubMed ID: 27992424
[TBL] [Abstract][Full Text] [Related]
14. Assessing progress in reducing the at-risk population after 13 years of the global programme to eliminate lymphatic filariasis.
Hooper PJ; Chu BK; Mikhailov A; Ottesen EA; Bradley M
PLoS Negl Trop Dis; 2014 Nov; 8(11):e3333. PubMed ID: 25411843
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic filariasis in children: clinical features, infection burdens and future prospects for elimination.
Shenoy RK; Bockarie MJ
Parasitology; 2011 Oct; 138(12):1559-68. PubMed ID: 21810306
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
Wilson NO; Badara Ly A; Cama VA; Cantey PT; Cohn D; Diawara L; Direny A; Fall M; Feeser KR; Fox LM; Kabore A; Seck AF; Sy N; Ndiaye D; Dubray C
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005198. PubMed ID: 27926918
[TBL] [Abstract][Full Text] [Related]
17. Profiling the best-performing community medicine distributors for mass drug administration: a comprehensive, data-driven analysis of treatment for schistosomiasis, lymphatic filariasis, and soil-transmitted helminths in Uganda.
Chami GF; Kabatereine NB; Tukahebwa EM
BMC Med; 2019 Mar; 17(1):69. PubMed ID: 30917824
[TBL] [Abstract][Full Text] [Related]
18. The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study.
Weil GJ; Bogus J; Christian M; Dubray C; Djuardi Y; Fischer PU; Goss CW; Hardy M; Jambulingam P; King CL; Kuttiat VS; Krishnamoorthy K; Laman M; Lemoine JF; O'Brian KK; Robinson LJ; Samuela J; Schechtman KB; Sircar A; Srividya A; Steer AC; Supali T; Subramanian S;
PLoS Med; 2019 Jun; 16(6):e1002839. PubMed ID: 31233507
[TBL] [Abstract][Full Text] [Related]
19. Treatment strategies underpinning the global programme to eliminate lymphatic filariasis.
Gyapong JO; Kumaraswami V; Biswas G; Ottesen EA
Expert Opin Pharmacother; 2005 Feb; 6(2):179-200. PubMed ID: 15757416
[TBL] [Abstract][Full Text] [Related]
20. The Health and Economic Burdens of Lymphatic Filariasis Prior to Mass Drug Administration Programs.
Mathew CG; Bettis AA; Chu BK; English M; Ottesen EA; Bradley MH; Turner HC
Clin Infect Dis; 2020 Jun; 70(12):2561-2567. PubMed ID: 31343064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
